Familial Adenomatous Polyposis Workup
- Author: Mohammad Wehbi, MD; Chief Editor: Julian Katz, MD more...
Laboratory Studies
- CBC count
- Alpha-fetoprotein (AFP) blood test - For children with FAP until age 5 years as part of a screening program for hepatoblastoma
Imaging Studies
- Flexible sigmoidoscopy: Visualization of more than 100 polyps usually establishes the diagnosis because of the diffuse nature of the polyposis.
- Colonoscopy is usually reserved for patients thought to have AAPC because of the higher incidence of right-sided polyps (proximal colonic involvement).
- Front- and side-viewing esophagogastroduodenoscopy is recommended if the sigmoidoscopy or the colonoscopy establishes the diagnosis of FAP. It is an essential component of the surveillance program in FAP, especially in that the second most common cancer involves the duodenum. This test helps to evaluate the presence of gastric, duodenal, and periampullary adenomas. It is recommended every 1-3 years. Benign gastric polyps are part of the spectrum of FAP. They are usually confined to the fundus.
- Dental and skull x-ray films are recommended in patients thought to have a Gardner variant of FAP. The films help to detect osteomas and dental abnormalities.
- Barium studies may be performed to visualize intestinal polyposis.
- Periodic ultrasounds or abdominal computed tomography scans are used to check for intra-abdominal desmoid tumors and pancreatic cancer.
- Periodic ultrasound of the thyroid: This imaging study is considered because of the increased risk of thyroid cancer. It can supplement the recommended annual physical examination of the thyroid.
Other Tests
- Three genetic tests are available.[10] Patients should receive genetic counseling from a trained individual prior to the performance of these tests.
- In vitro protein synthesis assay
- This is the genetic test of choice for the proband patient (patient with FAP). This test is commercially available.
- DNA from peripheral blood is analyzed for a truncated APC gene product.
- Because of the size of the APC protein, it is analyzed in 5 overlapping segments.
- If the proband has a mutation, other family members can be tested (after genetic counseling) for the identical mutation. The test generally has 100% accuracy in detecting other gene carriers in the family.
- APC gene sequencing is the most accurate test. However, it is hard logistically and, hence, is only reserved for research purposes.
- Linkage testing
- DNA markers near or in the APC locus are used to identify mutant gene carriers.
- This test requires 2 affected family members to achieve an appropriate linkage relationship resulting in 90% accuracy. As a result, this is not appropriate logistically.
Procedures
- Representative polyps should be removed by endoscopic polypectomy to confirm the diagnosis by histologic examination.[2, 11]
Histologic Findings
Characteristic pathology of a polyp from patients with FAP is a tubular adenoma.
Schulmann K, Pox C, Tannapfel A, Schmiegel W. The patient with multiple intestinal polyps. Best Practice & Research Clinical Gastroenterology [serial online]. June 2007;21(3):409-426. Available from: Science Direct. Accessed June 2, 2008. Available at http://www.sciencedirect.com.
Dekker E, Boparai KS, Poley JW, Mathus-Vliegen EM, Offerhaus GJ, Kuipers EJ, et al. High resolution endoscopy and the additional value of chromoendoscopy in the evaluation of duodenal adenomatosis in patients with familial adenomatous polyposis. Endoscopy. Aug 2009;41(8):666-9. [Medline].
Zhang J, Ahmad S, Mao Y. BubR1 and APC/EB1 cooperate to maintain metaphase chromosome alignment. J Cell Biol. Aug 27 2007;178(5):773-84. [Medline].
Newton K, Mallinson E, Bowen J, et al. Genotype-phenotype correlation in colorectal polyposis. Clin Genet. Jun 23 2011;[Medline].
Nieuwenhuis MH, De Vos Tot Nederveen Cappel W, Botma A, et al. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol. Feb 2008;6(2):215-9. [Medline].
Will OC, Hansmann A, Phillips RK, Palazzo FF, Meeran K, Marshall M, et al. Adrenal incidentaloma in familial adenomatous polyposis: a long-term follow-up study and schema for management. Dis Colon Rectum. Sep 2009;52(9):1637-44. [Medline].
Ponti G, Losi L, Pellacani G, Rossi GB, Presutti L, Mattioli F, et al. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA). Applied Immunohistochemistry & Molecular Morphology [serial online]. January 25, 2008;Available from: Pubmed. Accessed March 15, 2008. Available at http://www.appliedimmunohist.com/.
Bianchi LK, Burke CA, Bennett AE, et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. Feb 2008;6(2):180-5. [Medline].
Wachsmannova-Matelova L, Stevurkova V, Adamcikova Z, Holec V, Zajac V. Different phenotype manifestation of familial adenomatous polyposis in families with APC mutation at codon 1309. Neoplasma. 2009;56(6):486-9. [Medline].
Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB. The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer. Sep 17 2009;[Medline].
Douma KF, Bleiker EM, Aaronson NK, Cats A, Gerritsma MA, Gundy CM, et al. Long-term compliance with endoscopic surveillance advice for familial adenomatous polyposis (FAP). Colorectal Dis. Jul 10 2009;[Medline].
Friederich P, van Heumen BW, Nagtegaal ID, et al. Increased epithelial cell proliferation in the ileal pouch mucosa of patients with familial adenomatous polyposis. Virchows Arch. Sep 2007;451(3):659-67. [Medline]. [Full Text].
Iaquinto G, Fornasarig M, Quaia M, et al. Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc. Jan 2008;67(1):61-7. [Medline].
Johnson MD, Mackey R, Brown N, et al. Outcome based on management for duodenal adenomas: sporadic versus familial disease. J Gastrointest Surg. Nov 24 2009;[Medline].
Bresalier RS. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2006;2759-2810.
Brosens LA, Keller JJ, Offerhaus GJ, et al. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut. Jul 2005;54(7):1034-43. [Medline].
Burke CA, Beck GJ, Church JM, et al. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc. Mar 1999;49(3 Pt 1):358-64. [Medline].
Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology. May 2005;128(6):1696-716. [Medline].
Bussey HJR. Genetic and epidemiological features of familial polyposis coli. In: Bussey HJR, ed. Familial Polyposis Coli. Baltimore, Md: Johns Hopkins University Press; 1975:9-17.
Doxey BW, Kuwada SK, Burt RW. Inherited polyposis syndromes: molecular mechanisms, clinicopathology, and genetic testing. Clin Gastroenterol Hepatol. Jul 2005;3(7):633-41. [Medline].
Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. Feb 2006;101(2):385-98. [Medline].
Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. Mar 20 1997;336(12):823-7. [Medline].
Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. May 6 1993;328(18):1313-6. [Medline].
Giardiello FM, Yang VW, Hylind LM, et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med. Apr 4 2002;346(14):1054-9. [Medline].
Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. Feb 20 2002;94(4):252-66. [Medline].

